Volume | 450 |
|
|||||
News | - | ||||||
Day High | 11.20 | Low High |
|||||
Day Low | 11.20 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Bellevue Life Sciences Acquisition Corporation | BLACU | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
11.20 | 11.20 | 11.20 | 11.20 | 11.285 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
3 | 450 | US$ 11.20 | US$ 5,040 | - | 10.085 - 11.45 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 450 | US$ 11.20 | USD |
Bellevue Life Sciences Acquisition Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
68.99M | 6.43M | - | 0 | 404k | 0.06 | 170.86 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Bellevue Life Sciences A... News
Date | Time | Source | News Article |
---|---|---|---|
2/21/2024 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
2/13/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
2/08/2024 | 15:20 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
2/05/2024 | 12:48 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
11/16/2023 | 16:00 | PR Newswire (US) | OSR Holdings Co., Ltd. Enters Into Business Combination.. |
11/16/2023 | 15:37 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
11/16/2023 | 15:35 | Edgar (US Regulatory) | Form 8-K - Current report |
11/15/2023 | 05:04 | Edgar (US Regulatory) | Form 8-K - Current report |
11/07/2023 | 15:20 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
10/20/2023 | 15:20 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
10/10/2023 | 16:00 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
8/14/2023 | 15:45 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BLACU Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 11.20 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 11.20 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 10.73 | 11.285 | 10.73 | 10.96 | 85 | 0.47 | 4.38% |
6 Months | 10.6636 | 11.285 | 10.085 | 10.63 | 913 | 0.5364 | 5.03% |
1 Year | 10.4139 | 11.45 | 10.085 | 10.44 | 2,167 | 0.7861 | 7.55% |
3 Years | 10.17 | 11.45 | 10.085 | 10.21 | 15,446 | 1.03 | 10.13% |
5 Years | 10.17 | 11.45 | 10.085 | 10.21 | 15,446 | 1.03 | 10.13% |
Bellevue Life Sciences A... Description
Bellevue Life Sciences Acquisition Corp is a blank check company. |